Authors: Daniels, Julie T; Secker, Genevieve A; Shortt, Alex J; Tuft, Stephen J; Seetharaman, Shankar

Source: Regenerative Medicine, Volume 1, Number 5, September 2006 , pp. 715-719(5)

Publisher: Future Medicine

Abstract:

The concept of stem cell therapy has engaged the attention of the public and scientists alike. Intensive research effort is focused upon understanding the biology and therapeutic potential of embryonic and adult stem cells, with the eventual goal of treating such pathologies as Parkinson's disease, diabetes, neurological injury and degenerations and cancer. Ex vivo expansion and transplantation of limbal epithelial stem cells to the corneas to treat blinding ocular surface disease was one of the first stem cell therapies to successfully reach the clinic. However, limbal epithelial stem cell research and therapy delivery has remained largely within the noncommercial academic clinician-scientist environment from which it was originally pioneered. In our experience, gaining regulatory approval has been as great a hurdle as surmounting the scientific challenges of stem cell therapy. Based upon our model of delivering `accredited' limbal epithelial stem cell therapy to patients in compliance with Good Manufacturing Practice and the new European Union Tissues and Cells Directive, we address the key regulatory questions. This may help colleagues who are developing innovative academic research-driven stem cell therapies regarding donor consent, raw materials, quality assurance, laboratory specification, indemnity and funding.

Keywords: cornea; good manufacturing practice; regulation; stem cells; stem cell therapy

Document Type: Research article

DOI: http://dx.doi.org/10.2217/17460751.1.5.715

Affiliations: 1: 1Institute of Ophthalmology, University College London, 11-43 Bath Street, London, EC1V 9EL, UK., Email: j.daniels@ucl.ac.uk

Publication date: 2006-09-01

More about this publication?

• Regenerative Medicine provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats  vital to an increasingly time-constrained community.
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Information for Librarians
• E-Access Trials
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Biology ,  Medicine
• By this author: Daniels, Julie T ;  Secker, Genevieve A ;  Shortt, Alex J ;  Tuft, Stephen J ;  Seetharaman, Shankar

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers